Research by Kappelmann et al. demonstrated that elevated systemic inflammation markers, including CRP and IL-6, are significantly associated with both depression and impaired glycemic control, highlighting the bidirectional relationship between metabolic dysfunction and mental health [126]. This evidence concerns the gene CRP and depressive symptom measurement.